Aller au contenu
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Langue
Tous les champs
Titre
Auteur
Sujet
Cote
ISBN/ISSN
Tag
Rechercher
Recherche avancée
The clinical and cost-effectiv...
Citer
Envoyer par SMS
Envoyer par courriel
Imprimer
Exporter les notices
Exporter vers RefWorks
Exporter vers EndNoteWeb
Exporter vers EndNote
Permalien
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Afficher d'autres versions (2)
Détails bibliographiques
Auteurs principaux:
Clark, W
,
Jobanputra, P
,
Barton, P
,
Burls, A
Format:
Journal article
Publié:
2004
Exemplaires
Description
Autres Versions (2)
Documents similaires
Affichage MARC
Description
Résumé:
Documents similaires
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
par: Clark, W, et autres
Publié: (2004)
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
par: Clark, W, et autres
Publié: (2004)
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
par: W Clark, et autres
Publié: (2004-09-01)
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
par: Chen, Y, et autres
Publié: (2006)
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
par: Chen, Y, et autres
Publié: (2006)